Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Dominica Health Times.
Press releases published on July 17, 2025
SPR to Feature Five Abstracts on SPRINT® PNS at ASPN 2025
GlobeNewswire
·
July 17, 2025
- Data on chronic postoperative knee pain to be highlighted as a top abstract along with a first-ever look at SPRINT PNS in patients with migraine pain - CLEVELAND, July 17, 2025 (GLOBE NEWSWIRE) -- Leading pain medicine physicians will continue to expand …
Diverging Treatment Goals Emerge Between Hematologists and Nephrologists in aHUS Care, According to Spherix Global Insights
GlobeNewswire
·
July 17, 2025
EXTON, PA, July 17, 2025 (GLOBE NEWSWIRE) -- In the latest Special Topix™: Co-Management Approaches in aHUS (US), Spherix Global Insights explores the nuanced dynamics between hematologists and nephrologists in the management of atypical hemolytic uremic …
Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach
GlobeNewswire
·
July 17, 2025
FY25 revenue up 14.3% YOY FY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continue FY25 operating expenses lower by 24.5% YOY Negative EBITDA reduced by $5.7 …
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
GlobeNewswire
·
July 17, 2025
WARREN, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced the signing of a letter of intent to lease a 17,428-square-foot facility in New Jersey. The facility, formerly occupied by …
Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells
GlobeNewswire
·
July 17, 2025
PHOENIX, July 17, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company specializing in regenerative medicine, today announced that it has received a …
$7.80 Billion by 2030: Why Single-Use Surgical Instruments Are Reshaping Global Surgery | MarketsandMarkets™
GlobeNewswire
·
July 17, 2025
Delray Beach, FL, July 17, 2025 (GLOBE NEWSWIRE) -- What’s Driving the Global Shift from Reusables to Single-Use Surgical Tools? The global single-use surgical instruments market, valued at US$5.60 billion in 2024, stood at US$5.92 billion in 2025 and is …
Adventure Awaits: Make-A-Wish® Central and Northern Florida Makes Jeremy’s Dream Come True with a Thrilling Mexican Sport Fishing Adventure
GlobeNewswire
·
July 17, 2025
ORLANDO, Fla., July 17, 2025 (GLOBE NEWSWIRE) -- Make-A-Wish® Central and Northern Florida, in collaboration with Stan and Naomi Loomis, co-founders of Olympia and Wesley Pharmaceuticals, is excited to announce a heartfelt wish reveal for Jeremy, known …
Philips Launches ECG AI Marketplace to Enhance Early Cardiac Diagnosis
GlobeNewswire
·
July 17, 2025
July 17, 2025 Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution available through Philips’ ECG ecosystem CAMBRIDGE, Mass. — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the …
Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
·
July 17, 2025
SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today …
OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain
GlobeNewswire
·
July 17, 2025
LONDON and NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with …
RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD
GlobeNewswire
·
July 17, 2025
Acquisition contributes iCAD's commercial, technology, and regulatory capabilities The acquisition positions DeepHealth with an industry-leading suite of AI-powered breast cancer image interpretation and workflow solutions The combination is expected to …
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies
GlobeNewswire
·
July 17, 2025
SEATTLE, July 17, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, LLC, an innovative subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), is thrilled to announce a strategic partnership with an intent to acquire BioSpark AI Technologies Inc., a Vancouver- …
Tria Federal Expands VA Partnership with $174M Software Engineering & Development Award
GlobeNewswire
·
July 17, 2025
ARLINGTON, Va., July 17, 2025 (GLOBE NEWSWIRE) -- Tria Federal has received a $174 million contract award to provide expanded software engineering and development services to the Department of Veterans Affairs’ (VA) Financial Services Center (FSC). The …
Actuate Therapeutics Advances Clinical Program in Ewing Sarcoma After Positive Phase 1 Trial Demonstrates Complete and Partial Responses in Difficult-to-Treat Pediatric Sarcomas
GlobeNewswire
·
July 17, 2025
- Announces Completion of Phase 1 Study of Elraglusib in Pediatric Patients - Prolonged and Durable Complete Responses (CRs) Observed in Two of Ten Refractory Ewing Sarcoma Patients - Two Additional Patients Had Durable Stable Disease in Notoriously …
Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock
GlobeNewswire
·
July 17, 2025
Led by Strategic Industry Partner and Select Institutional Investors Proceeds Strengthen Balance Sheet and Support Commercialization of Innovation Strategy ST. LOUIS, July 17, 2025 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global …
Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer
GlobeNewswire
·
July 17, 2025
Dr. Zuraw led clinical development of telitacicept across MG, Sjögren’s, SLE, and RA at RemeGen, resulting in multiple regulatory approvals in China; brings deep U.S. and global development experience to support Vor Bio’s new development focus and …
BioNTech gibt den Rücktritt von Ryan Richardson aus dem Vorstand bekannt
GlobeNewswire
·
July 17, 2025
MAINZ, Deutschland, 17. Juli 2025 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) gab heute bekannt, dass Ryan Richardson zum 30. September 2025 im gegenseitigen Einvernehmen von seinen Funktionen als Chief Strategy Officer …
BioNTech Announces Ryan Richardson to Step Down from the Management Board
GlobeNewswire
·
July 17, 2025
MAINZ, Germany, July 17, 2025 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that Ryan Richardson will step down as Chief Strategy Officer in the Management Board of BioNTech on September 30, 2025, and as a Board …
Neurogen Biomarking to present novel data on at-home p-tau 217 testing for Alzheimer’s disease at Alzheimer’s Association International Conference® 2025
GlobeNewswire
·
July 17, 2025
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- Neurogen Biomarking will present novel data on at-home p-tau 217 testing for Alzheimer’s disease at the upcoming Alzheimer’s Association International Conference® (AAIC) in Toronto, Canada. Chief Scientific …
Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey
GlobeNewswire
·
July 17, 2025
ROSELAND, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the initiation of commercial sales of its …